©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 28, 2014; 20(40): 14805-14820
Published online Oct 28, 2014. doi: 10.3748/wjg.v20.i40.14805
Published online Oct 28, 2014. doi: 10.3748/wjg.v20.i40.14805
Table 3 Donor selection for fecal microbiota transplantation
| Absolute exclusion criteria[32,104,124] |
| Failed to provide informed consent |
| Systematic and local microbial infections (e.g., pathogenic bacteria, virus, ova and parasites) |
| Current communicable diseases |
| Malignancy and chemotherapeutics administration |
| Chronic gastrointestinal disorders |
| Peptic ulcer diseases |
| Gastroesophageal reflux disease |
| GI polyposis |
| Inflammatory bowel disease |
| Irritable bowel syndrome |
| Chronic constipation |
| Traveler’s diarrhea |
| Current GI symptoms |
| Antibiotics administration |
| Immunosuppressive agents and biological agents |
| Other medications impact on the gut microbiota (e.g., proton pump inhibitor, prokinetic agents, steroids, aspirin, probiotics, etc.) |
| High-risk lifestyles (e.g., intravenous drug abuse, risk sexual behaviors, etc.) |
| Relative exclusion criteria[32,104,124] |
| Age < 18 and > 70 yr |
| History of major GI surgery |
| Metabolic syndrome |
| Diabetes mellitus |
| Abnormal body mass index (< or > 18-25 kg/m2) |
| Systemic autoimmune disease |
| Atopic diseases(e.g., asthma and eczema) |
| Chronic pain syndromes (e.g., chronic fatigue syndrome and fibromyalgia) |
| Neuropsychiatric diseases |
- Citation: Wang ZK, Yang YS, Chen Y, Yuan J, Sun G, Peng LH. Intestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease. World J Gastroenterol 2014; 20(40): 14805-14820
- URL: https://www.wjgnet.com/1007-9327/full/v20/i40/14805.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i40.14805